- Home
- XTNT vs CNTB Comparison
XTNT vs CNTB Comparison
Compare XTNT & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- CNTB
- Stock Information
- Founded
- XTNT N/A
- CNTB 2012
- Country
- XTNT United States
- CNTB United States
- Employees
- XTNT N/A
- CNTB N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- XTNT Health Care
- CNTB Health Care
- Exchange
- XTNT Nasdaq
- CNTB Nasdaq
- Market Cap
- XTNT 60.9M
- CNTB 54.4M
- IPO Year
- XTNT N/A
- CNTB 2021
- Fundamental
- Price
- XTNT $0.65
- CNTB $1.46
- Analyst Decision
- XTNT
- CNTB Strong Buy
- Analyst Count
- XTNT 0
- CNTB 2
- Target Price
- XTNT N/A
- CNTB $7.50
- AVG Volume (30 Days)
- XTNT 86.4K
- CNTB 148.9K
- Earning Date
- XTNT 08-07-2025
- CNTB 09-04-2025
- Dividend Yield
- XTNT N/A
- CNTB N/A
- EPS Growth
- XTNT N/A
- CNTB N/A
- EPS
- XTNT N/A
- CNTB N/A
- Revenue
- XTNT $122,298,000.00
- CNTB $26,033,000.00
- Revenue This Year
- XTNT $11.64
- CNTB N/A
- Revenue Next Year
- XTNT $7.59
- CNTB N/A
- P/E Ratio
- XTNT N/A
- CNTB N/A
- Revenue Growth
- XTNT 20.81
- CNTB N/A
- 52 Week Low
- XTNT $0.33
- CNTB $0.51
- 52 Week High
- XTNT $0.83
- CNTB $1.60
- Technical
- Relative Strength Index (RSI)
- XTNT 48.08
- CNTB 72.56
- Support Level
- XTNT $0.60
- CNTB $1.05
- Resistance Level
- XTNT $0.78
- CNTB $1.56
- Average True Range (ATR)
- XTNT 0.05
- CNTB 0.13
- MACD
- XTNT -0.00
- CNTB 0.04
- Stochastic Oscillator
- XTNT 26.37
- CNTB 84.59
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.